News: Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
05:53pARBUTUS BIOPHARMA : Announces Abstract Selected for Publication at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - Form 8-K
PU
05:53pALTAGAS : Divestiture Will Provide Cash Proceeds to Fund Long-term Growth Opportunities and Continue to Strengthen Balance Sheet, While Concentrating AltaGas' Utilities Platform in the High Growth Eastern U.S - Form 6-K
PU
05:53pGLAXOSMITHKLINE : GSK unveils latest research advances demonstrating strength of its portfolio and pipeline at ASCO and EHA
PU
05:53pMIRATI THERAPEUTICS : Investigational Adagrasib Delivers Positive Results in Registration-Enabling Study of Patients with KRASG12C-Mutated Advanced Non-Small Cell Lung Cancer - Form 8-K
PU
05:53pADAGENE : Announces Publication at ASCO of Interim Monotherapy Dose Escalation Data Showing Compelling Safety Profile of Anti-CTLA-4 SAFEbody® ADG126, with Repeat Dosing Across Dose Levels - Form 6-K
PU
05:53pADICET BIO : Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL) - Form 8-K
PU
05:53pTURQUOISE HILL RESOURCES : MATERIAL CHANGE REPORT - Form 6-K
PU
05:53pMEREO BIOPHARMA : Announces the Presentation of Updated Data From a Phase 1b/2 Study of Etigilimab as a Poster at the 2022 American Society of Clinical Oncology Annual Meeting - Form 6-K
PU
05:53pZOVIO : REPORTS UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION - Form 8-K/A
PU
05:53pGXO LOGISTICS : NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION - Form 8-K
PU
05:53pDOGNESS (INTERNATIONAL) : INDEX TO UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K
PU
05:53pPDS BIOTECHNOLOGY : Biotech Announces Presentation of Data from NCI-Led Triple Combination Phase 2 Clinical Trial in Advanced, Refractory HPV-Positive Cancers at ASCO 2022 - Form 8-K
PU
05:53pAMERICAN EAGLE OUTFITTERS : AEO Inc. Reports First Quarter 2022 Results - Form 8-K
PU
05:53pVMWARE : Broadcom to Acquire VMware for Approximately $61 Billion in Cash and Stock - Form 8-K
PU
05:53pIOVANCE BIOTHERAPEUTICS : Announces Positive Clinical Data for Lifileucel in Advanced Melanoma - Form 8-K
PU
Discover
05:53pZYMEWORKS : ASCO 2022 - Form 8-K
PU
05:53pCOMFORT USA : SYSTEMS USA INCREASES AND EXTENDS DEBT FACILITY - Form 8-K
PU
05:53pLIZHI : Reports First Quarter 2022 Unaudited Financial Results - Form 6-K
PU
05:53pPDS BIOTECHNOLOGY : Biotech Announces Presentation of Efficacy and Safety Data from VERSATILE-002 Phase 2 Clinical Trial in Recurrent or Metastatic Head and Neck Cancer at ASCO 2022 - Form 8-K
PU
05:53pARAVIVE : Presents Updated Clinical Data at ASCO Showing Continued Best-in-Class Potential of Batiraxcept in Advanced or Metastatic clear cell Renal Cell Carcinoma (ccRCC) - Form 8-K
PU
05:53pELECTRA BATTERY MATERIALS : CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021 - Form 6-K
PU
05:53pVIETNAM ELECTRIC CABLE : Letter of announcement (27/05/2022)
PU
05:53pMERITOR : Shareholders Approve Acquisition By Cummins - Form 8-K
PU
05:52pSingtel 2nd Half Net Income Soared On Divestment Gains
DJ
05:50pDow gains 516 points as markets rally behind strong retail earnings
AQ
05:48pCORNERSTONE BUILDING INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA : Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cornerstone Building Brands, Inc. - CNR
PR
05:48pTechnology Shares Jump Amid Deal News -- Tech Roundup
DJ
05:47pVext to Announce Financial Results for Q1 2022 on May 30, 2022
AQ
05:46pTRECORA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA : Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Trecora Resources - TREC
PR
05:43pCN train carrying fuel derails in Saskatchewan; police say fuel may have leaked out
AQ
05:41pPrevent plant scenarios creep back in with clock ticking on northern U.S. -Braun
RE
05:40pNowVertical Group Reports First Quarter Financial Results
AQ
05:36pItalian court dismisses case against Tenaris's Chairman and Chief Executive Officer and two other Board members over allegedly improper payments
GL
05:34pMERITOR, INC. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05:34pCORRECTING and REPLACING Volatus Aerospace Corp. Announces Record First Quarter 2022 Sales
AQ
05:34pCORRECTING and REPLACING Volatus Aerospace Corp. Announces Record First Quarter 2022 Sales
EQ
05:32pMICHAEL DELL : Chipmaker Broadcom to buy VMware in $61 billion deal
RE
05:31pLEGACY EDUCATION ALLIANCE, INC. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05:31pRBC BEARINGS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
05:31pNote 2 - going concern, liquidity and management's plan
AQ
05:31pRestaurant Brands International Inc. to Participate in RBC Capital Markets 2022 Global Consumer & Retail Conference
PR
05:31pCandel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
GL
05:31pCandel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
GL
05:31pAscendant Resources Closes Final Tranche of Non-Brokered Private Placement
GL
05:31p4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
BU
05:31pAlpine Immune Sciences Announces Presentations at the 2022 EULAR and ASCO Annual Meetings
BU
05:31pMamaMancini's Holdings, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
GL
05:30pAscendant Resources Closes Final Tranche of Non-Brokered Private Placement
AQ
05:30pMamaMancini's Holdings, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
AQ
05:30pTRANSCRIPT : Maxeon Solar Technologies, Ltd., Q1 2022 Earnings Call, May 26, 2022
CI
05:30pTRANSCRIPT : Dell Technologies Inc., Q1 2023 Earnings Call, May 26, 2022
CI
05:29pARAVIVE, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05:29pONCTERNAL THERAPEUTICS, INC. : Other Events (form 8-K)
AQ
05:29pKYNDRYL HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
05:29pStorageVault Announces Results of Annual General and Special Shareholders Meeting
AQ
05:29pSummit Midstream Partners, LP Announces Adjournment of Annual Meeting and Information for Reconvened Annual Meeting
PR
05:27pAMERICAN EXPRESS CO : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05:27pINVO BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
05:27pCOLUMBIA BANKING SYSTEM, INC. : Regulation FD Disclosure (form 8-K)
AQ
05:27pNAVITAS SEMICONDUCTOR CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Prev.1   2  3  4  5  6  7  8  9  10Next